Plain-English translation of NCT06533462 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach called oral immunotherapy using a multiallergen powder — a powder containing tiny amounts of 10 common foods that trigger allergies in children (egg, milk, wheat, peanut, tree nuts, and others). The idea is that by eating gradually increasing amounts of this powder over time, young children's bodies may learn to tolerate these foods instead of having allergic reactions to them. The study will compare children who receive the active powder against children who receive a placebo (inactive powder) to see if the treatment helps.
Right now, there is no cure for food allergies, and families must strictly avoid the triggering foods. This study exists because oral immunotherapy has shown promise in older children, but it hasn't been thoroughly tested in very young children (under 3 years old). Researchers want to know if starting this treatment early, with a slow approach using multiple allergens at once, could help prevent or reduce food allergies in this young age group.
If you join this study, your child will first have a baseline food challenge test to confirm the allergy. Then you'll be randomly assigned to either receive the active multiallergen powder or a placebo powder. If your child receives the active treatment, you'll gradually increase the daily dose (up to about 3 teaspoons per day) over 2 years. Your child will have follow-up food challenge tests after 1 year and 2 years to see if tolerance has developed. Throughout the study, the research team will monitor your child for any reactions and provide guidance on feeding.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
Sweden